FEVR vs. BVIC, BAG, NICL, CCEP, CCH, GLB, OCDO, CWK, BME, and TATE
Should you be buying Fevertree Drinks stock or one of its competitors? The main competitors of Fevertree Drinks include Britvic (BVIC), A.G. BARR (BAG), Nichols (NICL), Coca-Cola Europacific Partners (CCEP), Coca-Cola HBC (CCH), Glanbia (GLB), Ocado Group (OCDO), Cranswick (CWK), B&M European Value Retail (BME), and Tate & Lyle (TATE). These companies are all part of the "consumer defensive" sector.
Fevertree Drinks vs. Its Competitors
Britvic (LON:BVIC) and Fevertree Drinks (LON:FEVR) are both consumer defensive companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership.
Britvic has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, Fevertree Drinks has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500.
In the previous week, Fevertree Drinks had 2 more articles in the media than Britvic. MarketBeat recorded 2 mentions for Fevertree Drinks and 0 mentions for Britvic. Fevertree Drinks' average media sentiment score of 1.37 beat Britvic's score of 0.00 indicating that Fevertree Drinks is being referred to more favorably in the news media.
Fevertree Drinks has a consensus price target of GBX 1,325, indicating a potential upside of 66.88%. Given Fevertree Drinks' stronger consensus rating and higher probable upside, analysts clearly believe Fevertree Drinks is more favorable than Britvic.
Britvic pays an annual dividend of GBX 32 per share. Fevertree Drinks pays an annual dividend of GBX 0.17 per share and has a dividend yield of 0.0%. Britvic pays out 61.9% of its earnings in the form of a dividend. Fevertree Drinks pays out 80.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Britvic has a net margin of 7.06% compared to Fevertree Drinks' net margin of 6.05%. Britvic's return on equity of 39.02% beat Fevertree Drinks' return on equity.
98.4% of Britvic shares are owned by institutional investors. Comparatively, 65.9% of Fevertree Drinks shares are owned by institutional investors. 9.2% of Britvic shares are owned by insiders. Comparatively, 12.6% of Fevertree Drinks shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Britvic has higher revenue and earnings than Fevertree Drinks. Britvic is trading at a lower price-to-earnings ratio than Fevertree Drinks, indicating that it is currently the more affordable of the two stocks.
Summary
Fevertree Drinks beats Britvic on 9 of the 17 factors compared between the two stocks.
Get Fevertree Drinks News Delivered to You Automatically
Sign up to receive the latest news and ratings for FEVR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding FEVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Fevertree Drinks Competitors List
Related Companies and Tools
This page (LON:FEVR) was last updated on 9/5/2025 by MarketBeat.com Staff
Free FEVR Stock Alerts